The stock was around $2.50 when the recent capital raise was being contemplated. In reading the agreement, if looks like a drop in the stock price does not constitute a material adverse change. If that's right, then the stock should go up from here if the deal gets done. If the new investor walks away... CRMB is in trouble. I think it's a good risk/reward from here- they got over saturated in NYC and that is hurting them. I'm buying here.